Intellia Therapeutics Financial Overview
Intellia Therapeutics's market cap is currently €927.80M. The company's EPS TTM is €-0.786138666; its P/E ratio is ―; Intellia Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is €-0.82. See an overview of income statement, balance sheet, and cash flow financials.
